Relationship between illness perception, fear of progression and quality of life in interstitial lung disease patients: A cross-sectional study
- PMID: 33998090
- DOI: 10.1111/jocn.15852
Relationship between illness perception, fear of progression and quality of life in interstitial lung disease patients: A cross-sectional study
Abstract
Aims and objectives: This study aimed to investigate whether fear of progression mediates the association between illness perception and quality of life among interstitial lung disease patients.
Background: So far, the physiological treatment of interstitial lung disease is limited. In addition to immunosuppressants such as glucocorticoids, two anti-fibrosis drugs (pirfenidone and nintedanib) have shown moderately beneficial effects on slowing the progression of interstitial lung disease fibrosis. However, none of these drugs has shown reliable or strong beneficial effects on improving quality of life. Psychological care and mental health support strategies focusing on improving patients' quality of life are particularly important.
Design: A cross-sectional study.
Methods: A convenience sample of patients suffering from interstitial lung disease were enrolled from August to December 2019. Data including sociodemographic and clinical characteristics, illness perception, fear of progression and quality of life were collected. The descriptive analysis and Pearson correlations were analysed by SPSS 26.0 (IBM Corp.). PROCESS v3.4 (by Andrew F. Hayes) macro was applied to analyse the mediating effects. We used the STROBE checklist to report the results.
Results: Both illness perception and fear of progression were correlated with quality of life. Fear of progression mediated the association between illness perception and quality of life. The indirect effect was 0.121, and the proportion of intermediary effect in the main effect was 26.36%.
Conclusion: Interstitial lung disease patients experience relatively poor quality of life and fear of progression exerts a mediating role between illness perception and quality of life.
Relevance to clinical practice: This study alerts medical staff to pay attention to negative illness perception and excessive fear, which is helpful to formulate effective interventions to manage interstitial lung disease patients' quality of life.
Keywords: fear of progression; illness perception; interstitial lung disease; nursing; quality of life.
© 2021 John Wiley & Sons Ltd.
Similar articles
-
Association between illness perception and social alienation among maintenance hemodialysis patients: The mediating role of fear of progression.PLoS One. 2024 Apr 2;19(4):e0301666. doi: 10.1371/journal.pone.0301666. eCollection 2024. PLoS One. 2024. PMID: 38564570 Free PMC article.
-
The relationship between symptom perception and fear of progression in patients with chronic heart failure: a multiple mediation analysis.Eur J Cardiovasc Nurs. 2023 Sep 5;22(6):638-646. doi: 10.1093/eurjcn/zvad024. Eur J Cardiovasc Nurs. 2023. PMID: 36748202
-
Relationship between fear of progression and quality of life in inflammatory bowel disease: Mediating role of health literacy and self-care.J Adv Nurs. 2024 Oct;80(10):4147-4160. doi: 10.1111/jan.16138. Epub 2024 Mar 5. J Adv Nurs. 2024. PMID: 38444116
-
Current approaches to the management of idiopathic pulmonary fibrosis.Respir Med. 2017 Aug;129:24-30. doi: 10.1016/j.rmed.2017.05.017. Epub 2017 May 30. Respir Med. 2017. PMID: 28732832 Review.
-
Diagnosis and Management of Fibrotic Interstitial Lung Diseases.Clin Chest Med. 2021 Jun;42(2):321-335. doi: 10.1016/j.ccm.2021.03.008. Clin Chest Med. 2021. PMID: 34024407 Review.
Cited by
-
Association between illness perception and social alienation among maintenance hemodialysis patients: The mediating role of fear of progression.PLoS One. 2024 Apr 2;19(4):e0301666. doi: 10.1371/journal.pone.0301666. eCollection 2024. PLoS One. 2024. PMID: 38564570 Free PMC article.
-
Fear of progression in patients with acute myocardial infarction: a cross-sectional study.BMC Nurs. 2024 Nov 28;23(1):866. doi: 10.1186/s12912-024-02552-1. BMC Nurs. 2024. PMID: 39609789 Free PMC article.
-
Development and initial validation of the ILD-Anxiety-Questionnaire (IAQ): A new instrument for assessing disease specific fears in interstitial lung disease.Chron Respir Dis. 2024 Jan-Dec;21:14799731241274785. doi: 10.1177/14799731241274785. Chron Respir Dis. 2024. PMID: 39186048 Free PMC article.
-
Anxiety and depression status in patients with idiopathic pulmonary fibrosis and outcomes of nintedanib treatment: an observational study.Ann Med. 2024 Dec;56(1):2323097. doi: 10.1080/07853890.2024.2323097. Epub 2024 Apr 6. Ann Med. 2024. PMID: 38581666 Free PMC article.
-
Latent profile analysis of fear of progression in Chinese hematologic malignancy survivors.Sci Rep. 2025 May 1;15(1):15265. doi: 10.1038/s41598-025-00415-6. Sci Rep. 2025. PMID: 40312507 Free PMC article.
References
REFERENCES
-
- Antoniou, K., Kamekis, A., Symvoulakis, E. K., Kokosi, M., & Swigris, J. J. (2020). Burden of idiopathic pulmonary fibrosis on patients' emotional well being and quality of life: A literature review. Current Opinion in Pulmonary Medicine, 26(5), 457-463. https://doi.org/10.1097/MCP.0000000000000703
-
- Arat, S., De Cock, D., Moons, P., Vandenberghe, J., & Westhovens, R. (2018). Modifiable correlates of illness perceptions in adults with chronic somatic conditions: A systematic review. Research in Nursing & Health, 41(2), 173-184. https://doi.org/10.1002/nur.21852
-
- Aydın Sayılan, A., & Demir Doğan, M. (2020). Illness perception, perceived social support and quality of life in patients with diagnosis of cancer. European Journal of Cancer Care, 29(4), e13252. https://doi.org/10.1111/ecc.13252
-
- Berry, C. E., Drummond, M. B., Han, M. L. K., Li, D., Fuller, C., Limper, A. H., Martinez, F. J., Schwarz, M. I., Sciurba, F. C., & Wise, R. A. (2012). Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease. Chest, 142(3), 704-711. https://doi.org/10.1378/chest.11-1332
-
- Bradley, B., Branley, H. M., Egan, J. J., Greaves, M. S., Hansell, D. M., Harrison, N. K., Hirani, N., Hubbard, R., Lake, F., Millar, A. B., Wallace, W. A., Wells, A. U., Whyte, M. K., Wilsher, M. L., British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee, Thoracic Society of Australia, New Zealand Thoracic Society & Irish Thoracic Society. (2008). Interstitial lung disease guideline: The British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax, 63(Suppl 5), v1-v58. https://doi.org/10.1136/thx.2008.101691
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical